This tool looks for unlabeled Wikidata items in your language. It starts with a Wikidata item,
looks at all the associated Wikipedia pages, the links on all those pages, and lists the Wikidata items corresponding to the link targets.
Q7876570 - No label in !
Searching link targets on 4 Wikipedias...
Item | Label [] | Wikilabels | Link # |
---|---|---|---|
Q8277 [CC | ] | No label in ! | Multiple sclerosis | טרשת נפוצה | Multiple Sklerose | Sclérose en plaques | 4 |
Q102507 [CC | ] | No label in ! | CAS Registry Number | CAS-Nummer | Numéro CAS | 3 |
Q824258 [CC | ] | No label in ! | International nonproprietary name | Internationaler Freiname | Dénomination commune internationale | 3 |
Q422248 [CC | ] | No label in ! | Monoclonal antibody | Monoklonaler Antikörper | Anticorps monoclonal | 3 |
Q192093 [CC | ] | No label in ! | Anatomical Therapeutic Chemical Classification System | Anatomisch-Therapeutisch-Chemisches Klassifikationssystem | 2 |
Q79460 [CC | ] | No label in ! | Antibody | נוגדן | 2 |
Q5009796 [CC | ] | No label in ! | CD20 | 2 |
Q1122544 [CC | ] | No label in ! | DrugBank | 2 |
Q204711 [CC | ] | No label in ! | Food and Drug Administration | 2 |
Q249619 [CC | ] | No label in ! | Immunosuppressive drug | Immunsuppressivum | 2 |
Q145623 [CC | ] | No label in ! | Molar mass | Molare Masse | 2 |
Q3077133 [CC | ] | No label in ! | Teriflunomide | אובג'יו | 2 |
Q188930 [CC | ] | No label in ! | לימפוציט B | B-Lymphozyt | 2 |
Q12140 [CC | ] | No label in ! | תרופה | Médicament | 2 |
Q434115 [CC | ] | No label in ! | ATC code L04 | 1 |
Q3603118 [CC | ] | No label in ! | Abagovomab | 1 |
Q2697833 [CC | ] | No label in ! | Abatacept | 1 |
Q4667244 [CC | ] | No label in ! | Abetimus | 1 |
Q25101921 [CC | ] | No label in ! | Abituzumab | 1 |
Q348260 [CC | ] | No label in ! | Adalimumab | 1 |
Q3605135 [CC | ] | No label in ! | Adecatumumab | 1 |
Q3606143 [CC | ] | No label in ! | Afelimomab | 1 |
Q4689286 [CC | ] | No label in ! | Aflibercept | 1 |
Q3609421 [CC | ] | No label in ! | Alefacept | 1 |
Q420164 [CC | ] | No label in ! | Alemtuzumab | 1 |
Q4740637 [CC | ] | No label in ! | Amatuximab | 1 |
Q4745081 [CC | ] | No label in ! | American Society of Health-System Pharmacists | 1 |
Q106957199 [CC | ] | No label in ! | Amivantamab | 1 |
Q415411 [CC | ] | No label in ! | Anakinra | 1 |
Q3615140 [CC | ] | No label in ! | Anatumomab mafenatox | 1 |
Q15708296 [CC | ] | No label in ! | Anifrolumab | 1 |
Q4774393 [CC | ] | No label in ! | Anti-lymphocyte globulin | 1 |
Q584065 [CC | ] | No label in ! | Anti-thymocyte globulin | 1 |
Q50573407 [CC | ] | No label in ! | Antifolate | 1 |
Q103537 [CC | ] | No label in ! | Antigen | 1 |
Q50429865 [CC | ] | No label in ! | Antimetabolite | 1 |
Q2858961 [CC | ] | No label in ! | Apremilast | 1 |
Q19903360 [CC | ] | No label in ! | Ascrinvacumab | 1 |
Q3624931 [CC | ] | No label in ! | Aselizumab | 1 |
Q20707748 [CC | ] | No label in ! | Atezolizumab | 1 |
Q3629019 [CC | ] | No label in ! | Atorolimumab | 1 |
Q27285470 [CC | ] | No label in ! | Avacopan | 1 |
Q18939 [CC | ] | No label in ! | Azathioprine | 1 |
Q4860707 [CC | ] | No label in ! | Baricitinib | 1 |
Q810010 [CC | ] | No label in ! | Basigin | 1 |
Q418702 [CC | ] | No label in ! | Basiliximab | 1 |
Q3637045 [CC | ] | No label in ! | Bavituximab | 1 |
Q3637405 [CC | ] | No label in ! | Bectumomab | 1 |
Q98139657 [CC | ] | No label in ! | Belantamab mafodotin | 1 |
Q4881990 [CC | ] | No label in ! | Belatacept | 1 |
Q1996249 [CC | ] | No label in ! | Belimumab | 1 |
Q4895713 [CC | ] | No label in ! | Bertilimumab | 1 |
Q413299 [CC | ] | No label in ! | Bevacizumab | 1 |
Q60785566 [CC | ] | No label in ! | Bimekizumab | 1 |
Q4919229 [CC | ] | No label in ! | Bivatuzumab mertansine | 1 |
Q410189 [CC | ] | No label in ! | Blinatumomab | 1 |
Q4926814 [CC | ] | No label in ! | Blisibimod | 1 |
Q422324 [CC | ] | No label in ! | Brentuximab vedotin | 1 |
Q3644426 [CC | ] | No label in ! | Briakinumab | 1 |
Q4972934 [CC | ] | No label in ! | Brodalumab | 1 |
Q25326688 [CC | ] | No label in ! | Brontictuzumab | 1 |
Q14897851 [CC | ] | No label in ! | CD154 | 1 |
Q4845302 [CC | ] | No label in ! | CD23 | 1 |
Q419458 [CC | ] | No label in ! | CD3 (immunology) | 1 |
Q412587 [CC | ] | No label in ! | CD4 | 1 |
Q21135811 [CC | ] | No label in ! | CD40 (protein) | 1 |
Q5009843 [CC | ] | No label in ! | CD80 | 1 |
Q420566 [CC | ] | No label in ! | Calcineurin | 1 |
Q3655009 [CC | ] | No label in ! | Canakinumab | 1 |
Q3656471 [CC | ] | No label in ! | Cantuzumab mertansine | 1 |
Q5034082 [CC | ] | No label in ! | Cantuzumab ravtansine | 1 |
Q48850560 [CC | ] | No label in ! | Carotuximab | 1 |
Q408155 [CC | ] | No label in ! | Catumaxomab | 1 |
Q5057039 [CC | ] | No label in ! | Cedelizumab | 1 |
Q412909 [CC | ] | No label in ! | Certolizumab pegol | 1 |
Q420296 [CC | ] | No label in ! | Cetuximab | 1 |
Q2311683 [CC | ] | No label in ! | ChemSpider | 1 |
Q83147 [CC | ] | No label in ! | Chemical formula | 1 |
Q24744759 [CC | ] | No label in ! | Chloramphenicol acetyltransferase | 1 |
Q367700 [CC | ] | No label in ! | Ciclosporin | 1 |
Q56615707 [CC | ] | No label in ! | Cirmtuzumab | 1 |
Q3678265 [CC | ] | No label in ! | Citatuzumab bogatox | 1 |
Q3678806 [CC | ] | No label in ! | Cixutumumab | 1 |
Q3680492 [CC | ] | No label in ! | Clenoliximab | 1 |
Q30612 [CC | ] | No label in ! | Clinical trial | 1 |
Q5133746 [CC | ] | No label in ! | ClinicalTrials.gov | 1 |
Q28456920 [CC | ] | No label in ! | Cofetuzumab pelidotin | 1 |
Q426181 [CC | ] | No label in ! | Complement component 5 | 1 |
Q3685951 [CC | ] | No label in ! | Conatumumab | 1 |
Q123574195 [CC | ] | No label in ! | Crovalimab | 1 |
Q3774751 [CC | ] | No label in ! | Cyclophilin | 1 |
Q953025 [CC | ] | No label in ! | Dacetuzumab | 1 |
Q412920 [CC | ] | No label in ! | Daclizumab | 1 |
Q5209305 [CC | ] | No label in ! | DailyMed | 1 |
Q5211586 [CC | ] | No label in ! | Dalotuzumab | 1 |
Q124407181 [CC | ] | No label in ! | Danicopan | 1 |
Q5222113 [CC | ] | No label in ! | Daratumumab | 1 |
Q5255127 [CC | ] | No label in ! | Demcizumab | 1 |
Q25326690 [CC | ] | No label in ! | Denintuzumab mafodotin | 1 |
Q28209069 [CC | ] | No label in ! | Depatuxizumab mafodotin | 1 |
Q3706232 [CC | ] | No label in ! | Detumomab | 1 |
Q113940477 [CC | ] | No label in ! | Deucravacitinib | 1 |
Q1150909 [CC | ] | No label in ! | Dihydroorotate dehydrogenase | 1 |
Q21011236 [CC | ] | No label in ! | Dinutuximab | 1 |
Q5308734 [CC | ] | No label in ! | Drozitumab | 1 |
Q5308897 [CC | ] | No label in ! | Drug nomenclature | 1 |
Q5308945 [CC | ] | No label in ! | Drugs.com | 1 |
Q5316908 [CC | ] | No label in ! | Dusigitumab | 1 |
Q48850524 [CC | ] | No label in ! | Duvortuxizumab | 1 |
Q3718768 [CC | ] | No label in ! | Ecromeximab | 1 |
Q421617 [CC | ] | No label in ! | Eculizumab | 1 |
Q749244 [CC | ] | No label in ! | Edrecolomab | 1 |
Q418270 [CC | ] | No label in ! | Efalizumab | 1 |
Q110271677 [CC | ] | No label in ! | Efgartigimod alfa | 1 |
Q120487796 [CC | ] | No label in ! | Efgartigimod alfa/hyaluronidase | 1 |
Q3723645 [CC | ] | No label in ! | Elotuzumab | 1 |
Q923443 [CC | ] | No label in ! | Elsilimomab | 1 |
Q25326691 [CC | ] | No label in ! | Emactuzumab | 1 |
Q28209889 [CC | ] | No label in ! | Emapalumab | 1 |
Q19904056 [CC | ] | No label in ! | Emibetuzumab | 1 |
Q19904068 [CC | ] | No label in ! | Enfortumab vedotin | 1 |
Q19904073 [CC | ] | No label in ! | Enoblituzumab | 1 |
Q5379455 [CC | ] | No label in ! | Enoticumab | 1 |
Q12182591 [CC | ] | No label in ! | Ensituximab | 1 |
Q119025940 [CC | ] | No label in ! | Epcoritamab | 1 |
Q3731886 [CC | ] | No label in ! | Erlizumab | 1 |
Q3732639 [CC | ] | No label in ! | Ertumaxomab | 1 |
Q415343 [CC | ] | No label in ! | Etanercept | 1 |
Q3733647 [CC | ] | No label in ! | Etaracizumab | 1 |
Q27265630 [CC | ] | No label in ! | Etrasimod | 1 |
Q421052 [CC | ] | No label in ! | Everolimus | 1 |
Q583864 [CC | ] | No label in ! | FKBP | 1 |
Q3739511 [CC | ] | No label in ! | Faralimomab | 1 |
Q3739631 [CC | ] | No label in ! | Farletuzumab | 1 |
Q5446524 [CC | ] | No label in ! | Ficlatuzumab | 1 |
Q430194 [CC | ] | No label in ! | Figitumumab | 1 |
Q19904163 [CC | ] | No label in ! | Filgotinib | 1 |
Q425137 [CC | ] | No label in ! | Fingolimod | 1 |
Q5457435 [CC | ] | No label in ! | Flanvotumab | 1 |
Q55639724 [CC | ] | No label in ! | Flotetuzumab | 1 |
Q3747524 [CC | ] | No label in ! | Fontolizumab | 1 |
Q123162030 [CC | ] | No label in ! | Frexalimab | 1 |
Q425158 [CC | ] | No label in ! | Fusion protein | 1 |
Q5510931 [CC | ] | No label in ! | Futuximab | 1 |
Q966412 [CC | ] | No label in ! | Galiximab | 1 |
Q5521322 [CC | ] | No label in ! | Ganitumab | 1 |
Q3758982 [CC | ] | No label in ! | Gavilimomab | 1 |
Q412685 [CC | ] | No label in ! | Gemtuzumab ozogamicin | 1 |
Q5564223 [CC | ] | No label in ! | Girentuximab | 1 |
Q3771944 [CC | ] | No label in ! | Glembatumumab vedotin | 1 |
Q117846135 [CC | ] | No label in ! | Glofitamab | 1 |
Q413879 [CC | ] | No label in ! | Golimumab | 1 |
Q3773206 [CC | ] | No label in ! | Gomiliximab | 1 |
Q15708315 [CC | ] | No label in ! | Guselkumab | 1 |
Q10910504 [CC | ] | No label in ! | Gusperimus | 1 |
Q5 [CC | ] | No label in ! | Human | 1 |
Q5939625 [CC | ] | No label in ! | Humanized antibody | 1 |
Q5971673 [CC | ] | No label in ! | IL-2 receptor | 1 |
Q635415 [CC | ] | No label in ! | Ibritumomab tiuxetan | 1 |
Q5986756 [CC | ] | No label in ! | Icrucumab | 1 |
Q6003939 [CC | ] | No label in ! | Imgatuzumab | 1 |
Q79455 [CC | ] | No label in ! | Immunoglobulin E | 1 |
Q1660194 [CC | ] | No label in ! | Immunomodulator | 1 |
Q1455316 [CC | ] | No label in ! | Immunosuppression | 1 |
Q1427096 [CC | ] | No label in ! | Immunotherapy | 1 |
Q6015706 [CC | ] | No label in ! | Indatuximab ravtansine | 1 |
Q3798310 [CC | ] | No label in ! | Indium (111In) altumomab pentetate | 1 |
Q3798313 [CC | ] | No label in ! | Indium (111In) capromab pendetide | 1 |
Q3792457 [CC | ] | No label in ! | Indium (111In) igovomab | 1 |
Q3798316 [CC | ] | No label in ! | Indium (111In) satumomab pendetide | 1 |
Q25326696 [CC | ] | No label in ! | Inebilizumab | 1 |
Q415264 [CC | ] | No label in ! | Infliximab | 1 |
Q3799026 [CC | ] | No label in ! | Inolimomab | 1 |
Q3799041 [CC | ] | No label in ! | Inotuzumab ozogamicin | 1 |
Q409715 [CC | ] | No label in ! | Integrin | 1 |
Q188269 [CC | ] | No label in ! | Interferon | 1 |
Q194908 [CC | ] | No label in ! | Interleukin | 1 |
Q2409681 [CC | ] | No label in ! | Interleukin 12 | 1 |
Q99486570 [CC | ] | No label in ! | Interleukin 17 | 1 |
Q410130 [CC | ] | No label in ! | Interleukin 2 | 1 |
Q23308590 [CC | ] | No label in ! | Interleukin 23 | 1 |
Q14877650 [CC | ] | No label in ! | Interleukin 5 | 1 |
Q412889 [CC | ] | No label in ! | Interleukin 6 | 1 |
Q18027836 [CC | ] | No label in ! | Interleukin-6 receptor | 1 |
Q6057485 [CC | ] | No label in ! | Intetumumab | 1 |
Q20707821 [CC | ] | No label in ! | Iodine (131 I) derlotuximab biotin | 1 |
Q2459042 [CC | ] | No label in ! | Ipilimumab | 1 |
Q76803684 [CC | ] | No label in ! | Iptacopan | 1 |
Q3801853 [CC | ] | No label in ! | Iratumumab | 1 |
Q20707906 [CC | ] | No label in ! | Isatuximab | 1 |
Q30314127 [CC | ] | No label in ! | Istiratumab | 1 |
Q13574436 [CC | ] | No label in ! | Ixekizumab | 1 |
Q909442 [CC | ] | No label in ! | KEGG | 1 |
Q3814375 [CC | ] | No label in ! | Keliximab | 1 |
Q4042403 [CC | ] | No label in ! | L-selectin | 1 |
Q3825147 [CC | ] | No label in ! | Labetuzumab | 1 |
Q3829321 [CC | ] | No label in ! | Lebrikizumab | 1 |
Q248550 [CC | ] | No label in ! | Leflunomide | 1 |
Q425681 [CC | ] | No label in ! | Lenalidomide | 1 |
Q3830773 [CC | ] | No label in ! | Lerdelimumab | 1 |
Q1112374 [CC | ] | No label in ! | Lexatumumab | 1 |
Q20708086 [CC | ] | No label in ! | Lifastuzumab vedotin | 1 |
Q17131070 [CC | ] | No label in ! | Lilotomab | 1 |
Q3833129 [CC | ] | No label in ! | Lintuzumab | 1 |
Q217094 [CC | ] | No label in ! | List of withdrawn drugs | 1 |
Q39057117 [CC | ] | No label in ! | Loncastuximab tesirine | 1 |
Q527070 [CC | ] | No label in ! | Lorvotuzumab mertansine | 1 |
Q931315 [CC | ] | No label in ! | Lucatumumab | 1 |
Q3840604 [CC | ] | No label in ! | Lumiliximab | 1 |
Q25326693 [CC | ] | No label in ! | Lumretuzumab | 1 |
Q4042438 [CC | ] | No label in ! | Lymphocyte function-associated antigen 1 | 1 |
Q285613 [CC | ] | No label in ! | MTOR | 1 |
Q422687 [CC | ] | No label in ! | Macrolide | 1 |
Q6753781 [CC | ] | No label in ! | Mapatumumab | 1 |
Q109356831 [CC | ] | No label in ! | Margetuximab | 1 |
Q3850818 [CC | ] | No label in ! | Maslimomab | 1 |
Q905928 [CC | ] | No label in ! | Matuzumab | 1 |
Q557919 [CC | ] | No label in ! | MedlinePlus | 1 |
Q3306175 [CC | ] | No label in ! | Mepolizumab | 1 |
Q6823403 [CC | ] | No label in ! | Metelimumab | 1 |
Q422232 [CC | ] | No label in ! | Methotrexate | 1 |
Q3857819 [CC | ] | No label in ! | Milatuzumab | 1 |
Q6869421 [CC | ] | No label in ! | Minretumomab | 1 |
Q115285803 [CC | ] | No label in ! | Mirvetuximab soravtansine | 1 |
Q6883597 [CC | ] | No label in ! | Mitumomab | 1 |
Q14605026 [CC | ] | No label in ! | Morolimumab | 1 |
Q2751034 [CC | ] | No label in ! | Mouse | 1 |
Q14605217 [CC | ] | No label in ! | Moxetumomab pasudotox | 1 |
Q416494 [CC | ] | No label in ! | Muromonab-CD3 | 1 |
Q420553 [CC | ] | No label in ! | Mycophenolic acid | 1 |
Q6957316 [CC | ] | No label in ! | Nacolomab tafenatox | 1 |
Q6965148 [CC | ] | No label in ! | Naptumomab estafenatox | 1 |
Q6966071 [CC | ] | No label in ! | Narnatumab | 1 |
Q386119 [CC | ] | No label in ! | Natalizumab | 1 |
Q103085694 [CC | ] | No label in ! | Naxitamab | 1 |
Q6985503 [CC | ] | No label in ! | Necitumumab | 1 |
Q1216998 [CC | ] | No label in ! | Neoplasm | 1 |
Q6996050 [CC | ] | No label in ! | Nerelimomab | 1 |
Q6998092 [CC | ] | No label in ! | Nesvacumab | 1 |
Q3877039 [CC | ] | No label in ! | Nimotuzumab | 1 |
Q7041828 [CC | ] | No label in ! | Nivolumab | 1 |
Q389496 [CC | ] | No label in ! | Obinutuzumab | 1 |
Q7075663 [CC | ] | No label in ! | Ocaratuzumab | 1 |
Q2013780 [CC | ] | No label in ! | Ocrelizumab | 1 |
Q7078368 [CC | ] | No label in ! | Odulimomab | 1 |
Q410656 [CC | ] | No label in ! | Ofatumumab | 1 |
Q7083108 [CC | ] | No label in ! | Olaratumab | 1 |
Q7088501 [CC | ] | No label in ! | Olokizumab | 1 |
Q415392 [CC | ] | No label in ! | Omalizumab | 1 |
Q7091711 [CC | ] | No label in ! | Onartuzumab | 1 |
Q15708295 [CC | ] | No label in ! | Ontuxizumab | 1 |
Q3884218 [CC | ] | No label in ! | Oportuzumab monatox | 1 |
Q7101491 [CC | ] | No label in ! | Oregovomab | 1 |
Q7108506 [CC | ] | No label in ! | Otelixizumab | 1 |
Q15708277 [CC | ] | No label in ! | Otlertuzumab | 1 |
Q21098986 [CC | ] | No label in ! | Ozanimod | 1 |
Q417775 [CC | ] | No label in ! | Panitumumab | 1 |
Q7139934 [CC | ] | No label in ! | Parsatuzumab | 1 |
Q7141848 [CC | ] | No label in ! | Pascolizumab | 1 |
Q7148077 [CC | ] | No label in ! | Patritumab | 1 |
Q27088288 [CC | ] | No label in ! | Peficitinib | 1 |
Q106863504 [CC | ] | No label in ! | Pegcetacoplan | 1 |
Q13896859 [CC | ] | No label in ! | Pembrolizumab | 1 |
Q7162047 [CC | ] | No label in ! | Pemtumomab | 1 |
Q1998021 [CC | ] | No label in ! | Pertuzumab | 1 |
Q7179565 [CC | ] | No label in ! | Pexelizumab | 1 |
Q7180990 [CC | ] | No label in ! | Phases of clinical research | 1 |
Q417489 [CC | ] | No label in ! | Pimecrolimus | 1 |
Q19946117 [CC | ] | No label in ! | Pinatuzumab vedotin | 1 |
Q19946115 [CC | ] | No label in ! | Polatuzumab vedotin | 1 |
Q930144 [CC | ] | No label in ! | Polyclonal antibodies | 1 |
Q7227206 [CC | ] | No label in ! | Pomalidomide | 1 |
Q18604129 [CC | ] | No label in ! | Ponesimod | 1 |
Q1643563 [CC | ] | No label in ! | Prescription drug | 1 |
Q7245992 [CC | ] | No label in ! | Pritumumab | 1 |
Q19652 [CC | ] | No label in ! | Public domain | 1 |
Q7279820 [CC | ] | No label in ! | Racotumomab | 1 |
Q7281693 [CC | ] | No label in ! | Radretumab | 1 |
Q7290345 [CC | ] | No label in ! | Ramucirumab | 1 |
Q55641547 [CC | ] | No label in ! | Ravulizumab | 1 |
Q573538 [CC | ] | No label in ! | Regulation of therapeutic goods | 1 |
Q7315650 [CC | ] | No label in ! | Reslizumab | 1 |
Q2151796 [CC | ] | No label in ! | Ridaforolimus | 1 |
Q7334300 [CC | ] | No label in ! | Rilonacept | 1 |
Q7334301 [CC | ] | No label in ! | Rilotumumab | 1 |
Q25112466 [CC | ] | No label in ! | Risankizumab | 1 |
Q120487896 [CC | ] | No label in ! | Ritlecitinib | 1 |
Q412323 [CC | ] | No label in ! | Rituximab | 1 |
Q7340759 [CC | ] | No label in ! | Robatumumab | 1 |
Q48975959 [CC | ] | No label in ! | Rosmantuzumab | 1 |
Q621636 [CC | ] | No label in ! | Route of administration | 1 |
Q30314129 [CC | ] | No label in ! | Rovalpituzumab tesirine | 1 |
Q3941929 [CC | ] | No label in ! | Rovelizumab | 1 |
Q120491843 [CC | ] | No label in ! | Rozanolixizumab | 1 |
Q7380420 [CC | ] | No label in ! | Ruplizumab | 1 |
Q23901469 [CC | ] | No label in ! | Sacituzumab govitecan | 1 |
Q7424081 [CC | ] | No label in ! | Sarilumab | 1 |
Q58218746 [CC | ] | No label in ! | Satralizumab | 1 |
Q7444755 [CC | ] | No label in ! | Secukinumab | 1 |
Q19946112 [CC | ] | No label in ! | Seribantumab | 1 |
Q3960028 [CC | ] | No label in ! | Sibrotuzumab | 1 |
Q3960572 [CC | ] | No label in ! | Siltuximab | 1 |
Q7521275 [CC | ] | No label in ! | Simtuzumab | 1 |
Q7525805 [CC | ] | No label in ! | Siplizumab | 1 |
Q25100876 [CC | ] | No label in ! | Siponimod | 1 |
Q32089 [CC | ] | No label in ! | Sirolimus | 1 |
Q7530673 [CC | ] | No label in ! | Sirukumab | 1 |
Q21098906 [CC | ] | No label in ! | Sofituzumab vedotin | 1 |
Q7558265 [CC | ] | No label in ! | Solitomab | 1 |
Q111172579 [CC | ] | No label in ! | Spesolimab | 1 |
Q60785670 [CC | ] | No label in ! | Sutimlimab | 1 |
Q193529 [CC | ] | No label in ! | T cell | 1 |
Q1536078 [CC | ] | No label in ! | TNF inhibitor | 1 |
Q411648 [CC | ] | No label in ! | Tacrolimus | 1 |
Q7679593 [CC | ] | No label in ! | Talizumab | 1 |
Q7684711 [CC | ] | No label in ! | Taplitumomab paptox | 1 |
Q25098812 [CC | ] | No label in ! | Tarextumab | 1 |
Q637504 [CC | ] | No label in ! | Technetium (99mTc) arcitumomab | 1 |
Q7692229 [CC | ] | No label in ! | Technetium (99mTc) nofetumomab merpentan | 1 |
Q7692230 [CC | ] | No label in ! | Technetium (99mTc) pintumomab | 1 |
Q15708812 [CC | ] | No label in ! | Technetium (99mTc) votumumab | 1 |
Q7697277 [CC | ] | No label in ! | Telimomab aritox | 1 |
Q7699074 [CC | ] | No label in ! | Temsirolimus | 1 |
Q7699508 [CC | ] | No label in ! | Tenatumomab | 1 |
Q7699688 [CC | ] | No label in ! | Teneliximab | 1 |
Q7701358 [CC | ] | No label in ! | Teplizumab | 1 |
Q7701391 [CC | ] | No label in ! | Teprotumumab | 1 |
Q203174 [CC | ] | No label in ! | Thalidomide | 1 |
Q3991247 [CC | ] | No label in ! | Tigatuzumab | 1 |
Q15708331 [CC | ] | No label in ! | Tildrakizumab | 1 |
Q108670929 [CC | ] | No label in ! | Tisotumab vedotin | 1 |
Q425154 [CC | ] | No label in ! | Tocilizumab | 1 |
Q3530324 [CC | ] | No label in ! | Tofacitinib | 1 |
Q7825392 [CC | ] | No label in ! | Toralizumab | 1 |
Q3995913 [CC | ] | No label in ! | Tositumomab | 1 |
Q7829477 [CC | ] | No label in ! | Tovetumab | 1 |
Q412616 [CC | ] | No label in ! | Trastuzumab | 1 |
Q80109553 [CC | ] | No label in ! | Trastuzumab deruxtecan | 1 |
Q3997863 [CC | ] | No label in ! | Trastuzumab emtansine | 1 |
Q7841565 [CC | ] | No label in ! | Trifunctional antibody | 1 |
Q4000172 [CC | ] | No label in ! | Tucotuzumab celmoleukin | 1 |
Q7881588 [CC | ] | No label in ! | Umirolimus | 1 |
Q6593799 [CC | ] | No label in ! | Unique Ingredient Identifier | 1 |
Q27074125 [CC | ] | No label in ! | Upadacitinib | 1 |
Q420305 [CC | ] | No label in ! | Ustekinumab | 1 |
Q25326695 [CC | ] | No label in ! | Vandortuzumab vedotin | 1 |
Q7915216 [CC | ] | No label in ! | Vantictumab | 1 |
Q25326698 [CC | ] | No label in ! | Vanucizumab | 1 |
Q7915305 [CC | ] | No label in ! | Vapaliximab | 1 |
Q7918002 [CC | ] | No label in ! | Vedolizumab | 1 |
Q4009438 [CC | ] | No label in ! | Veltuzumab | 1 |
Q7920695 [CC | ] | No label in ! | Vepalimomab | 1 |
Q7936102 [CC | ] | No label in ! | Visilizumab | 1 |
Q7939256 [CC | ] | No label in ! | Voclosporin | 1 |
Q7941885 [CC | ] | No label in ! | Vorsetuzumab mafodotin | 1 |
Q37155 [CC | ] | No label in ! | WHO Model List of Essential Medicines | 1 |
Q7817 [CC | ] | No label in ! | World Health Organization | 1 |
Q7381696 [CC | ] | No label in ! | Yttrium (90Y) clivatuzumab tetraxetan | 1 |
Q3980015 [CC | ] | No label in ! | Yttrium (90Y) tacatuzumab tetraxetan | 1 |
Q8065569 [CC | ] | No label in ! | Zalutumumab | 1 |
Q8066254 [CC | ] | No label in ! | Zanolimumab | 1 |
Q17107865 [CC | ] | No label in ! | Zolbetuximab | 1 |
Q8073564 [CC | ] | No label in ! | Zolimomab aritox | 1 |
Q15410168 [CC | ] | No label in ! | Zotarolimus | 1 |
Q6844 [CC | ] | No label in ! | נגיף הפטיטיס B | 1 |
Q21418091 [CC | ] | No label in ! | Antikörperabhängige zellvermittelte Zytotoxizität | 1 |
Q18749628 [CC | ] | No label in ! | Arzneimittelzulassung | 1 |
Q679692 [CC | ] | No label in ! | Biopharmazeutikum | 1 |
Q4970200 [CC | ] | No label in ! | British Journal of Haematology | 1 |
Q1203577 [CC | ] | No label in ! | Deutsche Multiple Sklerose Gesellschaft | 1 |
Q25670 [CC | ] | No label in ! | Digital Object Identifier | 1 |
Q423252 [CC | ] | No label in ! | Disulfidbrücke | 1 |
Q130146 [CC | ] | No label in ! | Europäische Arzneimittel-Agentur | 1 |
Q458 [CC | ] | No label in ! | Europäische Union | 1 |
Q17053974 [CC | ] | No label in ! | Fucosylierung | 1 |
Q978273 [CC | ] | No label in ! | Hybridom-Technik | 1 |
Q79448 [CC | ] | No label in ! | Immunglobulin G | 1 |
Q1369403 [CC | ] | No label in ! | Intravenös | 1 |
Q899763 [CC | ] | No label in ! | Primärstruktur | 1 |
Q21014462 [CC | ] | No label in ! | Zelllinie | 1 |
Q226329 [CC | ] | No label in ! | Injection | 1 |
Q30 [CC | ] | No label in ! | États-Unis | 1 |